Was kommt nach Natalizumab?
Crossref DOI link: https://doi.org/10.1007/s15005-017-2019-2
Published Online: 2017-01-24
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Limmroth, Volker